Compass Therapeutics Stock In The News
| CMPX Stock | USD 2.46 0.01 0.40% |
Our overall analysis of Compass Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Compass Therapeutics. The specific impact of Compass Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Compass Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Compass Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Compass Therapeutics Backtesting and Compass Therapeutics Hype Analysis. For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.
Compass |
Compass Therapeutics Today Top News and Investor Outlook
Compass Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Compass and other traded companies coverage with news coverage. We help investors stay connected with Compass headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Compass Stock performance. Please note that trading solely based on the Compass Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Compass Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Compass earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Compass Therapeutics that are available to investors today. That information is available publicly through Compass media outlets and privately through word of mouth or via Compass internal channels. However, regardless of the origin, that massive amount of Compass data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Compass Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compass Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compass Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compass Therapeutics alpha.
Compass Largest EPS Surprises
Earnings surprises can significantly impact Compass Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-03 | 2023-06-30 | -0.08 | -0.09 | -0.01 | 12 | ||
2025-02-27 | 2024-12-31 | -0.0944 | -0.11 | -0.0156 | 16 | ||
2024-03-21 | 2023-12-31 | -0.09 | -0.11 | -0.02 | 22 | ||
2021-11-12 | 2021-09-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2024-11-12 | 2024-09-30 | -0.11 | -0.08 | 0.03 | 27 | ||
2024-05-13 | 2024-03-31 | -0.11 | -0.08 | 0.03 | 27 |
Compass Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Compass Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Compass Therapeutics Projected to Post Earnings on Thursday - Defense World at news.google.com
5th of March 2025
Short Interest in Compass Therapeutics, Inc. Expands By 28.4 at thelincolnianonline.com
28th of February 2025
Compass Therapeutics Inc Reports Annual EPS of -0.36, Revenue of 0.88 Million for 2024 at gurufocus.com
25th of February 2025
Investment Analysts Updated EPS Estimates for February 25th at thelincolnianonline.com
19th of February 2025
Piper Sandler initiates coverage on Compass Therapeutics with overweight rating - TradingV... at news.google.com
13th of February 2025
Acquisition by Shin Barry of 250000 shares of Compass Therapeutics at 3.65 subject to Rule... at MacroaxisInsider
11th of February 2025
How Is Compass Therapeutics Gaining Market Traction at kalkinemedia.com
4th of February 2025
Why Compass Therapeutics Inc Is Skyrocketing So Far In 2025 at insidermonkey.com
31st of January 2025
Compass Therapeutics Stock Skyrockets 108 percent in a Month Heres Why at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Compass Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Compass Therapeutics' short interest history, or implied volatility extrapolated from Compass Therapeutics options trading.
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.